HIV/AIDS, Tuberculosis (TB), and STIs. Infections and Infestations HIV/AIDS, Tuberculosis (TB), and STIs.
Conditions
Interventions
The trial is comparing educational outreach (based on guidelines) to passive dissemination of these guidelines to all nurses in control clinics combined with traditional off-site didactic training of
Sponsors
University of Cape Town Lung Institute (South Africa)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Clusters: primary care clinics participating in the first phases of the rollout of the national AntiRetroviral Treatment (ART) programme in the Free State province, South Africa Patients: All patients enrolled in the national ART programme at these clinics PALSA PLUS Western Cape trial: In addition to the above inclusion criteria, the PALSA PLUS Western Cape trial will also include primary care facilities where care for HIV and TB is provided. Patients: all patients 15 years or older attending these facilities for the trial duration (36 weeks).
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. TB case detection 2. Voluntary counselling and testing uptake 3. Cotrimoxazole prophylaxis provision | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. TB screening (sputum sampling) 2. Proportion of ART patients with undetectable viral loads at 6,12 and 18 months 3. Health-related quality of life 4. Hospitalisation 5. Mortality 6. Antiretroviral treatment interruptions | — |
Countries
South Africa
Outcome results
None listed